The biotechnological company Altos Labs, the Dr. Pedro Guillén Foundation and CEMTRO Clinic have today signed a historic collaboration agreement in biomedical research that aims to study the rejuvenation of body tissue through cell reprogramming.
The event was attended by the Mayor of Madrid himself, José Luis Martínez-Almeida, interested in this agreement that will materialize in research projects to deepen knowledge of the diseases that affect the musculoskeletal system, including those related to aging, in order to find new treatments for the same.
The members of the Board of Directors of Altos Labs, Rick Klausner, chief scientist and founder of the company; Hal Barron, CEO; Hans Bishop, President; Herbert “Skip” Virgin, medical director, Juan Carlos Izpisúa Belmonte, director of the San Diego Scientific Institute and Nobel Prize winner Shinya Yamanaka, visited the CEMTRO Clinic facilities today to see the hospital and sign the agreement.
The directors and scientists of Altos Labs have unveiled, together with Professor Pedro Guillén, founder and president of Clínica CEMTRO, and with the presence of the Mayor of Madrid, a plaque commemorating the signing of the agreement.
After that, Guillén and the hospital’s board of directors accompanied the Altos Labs group on a tour of the center, where they were able to see first-hand the high technology that the hospital has, the operating room facilities and the clean room cell culture, among other spaces.
“My dream as a traumatologist and researcher is to be able to die young as late as possible,” said Guillén.